NAGAKAWA Osamu 永川修

Researcher Number	00217978
Affiliation (based on the past Project Information) *help	2006: University of Toyama, Department of Urology, Assistant professor, 大学院医学薬学研究部, 講師 2005: 富山大学, 医学部, 講師 2004: University Hospital, Urology, Assistant Professor, 附属病院, 講師 2003: 富山医科薬科大学, 医学部附属病院, 講師 1998 – 1999: 富山医科薬科大学, 医学部, 講師
Review Section/Research Field	Principal Investigator Urology / Urology Except Principal Investigator Urology
Keywords	Principal Investigator 前立腺癌 / 浸潤 / invasion / VIP / PACAP / IL-6 / 神経ペプチド / クロモグラニンA / パンクレアスタチン / GRP … More Except Principal Investigator HGF / 前立腺癌 / アンドロゲン受容体 / 浸潤、転移 / 細胞外マトリクス / ケモカイン / HGF関連因子 / 浸潤 / 転移 / prostate cancer / androgen receptor / invasion / extracellular matrices / chemokine / HAI-1 / metastasis Less

Androgen receptor influences the invasion and metastasis in prostate cancer molecular biological study
- Principal Investigator
  
  FUSE Hideki
- Project Period (FY)
  2005 – 2006
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  University of Toyama
Effect of VIP on invasion and production of IL-6 in prostate cancer cellsPrincipal Investigator
- Principal Investigator
  
  NAGAKAWA Osamu
- Project Period (FY)
  2003 – 2004
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  TOYAMA MEDICAL AND PHARMACEUTICAL UNIVERSITY
Effect of Proatatic Neuripeptides on The Invasion of Prostate Cancer Cells.Principal Investigator
- Principal Investigator
  
  NAGAKAWA Osamu
- Project Period (FY)
  1998 – 1999
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  TOYAMA MEDICAL AND PHARMACEUTICAL UNIVERSITY

All 2006 2005 2004 2003

All Journal Article

[Journal Article] Androgen receptor negatively influences the expression of chemokine receptors (CXCR4, CCR1) and ligand-mediated migration in prostate cancer DU-145.2006
- Author(s)
  Akashi, Nagakawa, Fuse, et al.
- Journal Title
  
  Oncology Reports 16(4)
  
  Pages: 831-836
- Data Source
  KAKENHI-PROJECT-17591668
[Journal Article] Serum hepatocyte growth factor activator inhibitor type 1(HAI-1) and type 2(HAI-2) in prostate cancer. Prostate2006
- Author(s)
  Nagakawa O. et al.
- Journal Title
  
  Prostate 66(5)
  
  Pages: 447-452
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17591668
[Journal Article] Treatment with prednisolone of hormone-refractory prostate cancer.2006
- Author(s)
  Fuse Nagakawa, et al.
- Journal Title
  
  Arch.Andol. 52(1)
  
  Pages: 35-38
- Data Source
  KAKENHI-PROJECT-17591668
[Journal Article] Serum hepatocyte growth factor activator inhibitor type 1 (HAI-1) and type 2 (HAI-2) in prostate cancer2006
- Author(s)
  Nagakawa O. et al.
- Journal Title
  
  Prostate 66(5)
  
  Pages: 447-452
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17591668
[Journal Article] Serum hepatocyte growth factor activator inhibitor type 1(HAI-1) and type 2(HAI-2) in prostate cancer.2006
- Author(s)
  Nagakawa, Fuse et al.
- Journal Title
  
  Prostate 66(5)
  
  Pages: 447-452
- Data Source
  KAKENHI-PROJECT-17591668
[Journal Article] Serum hepatocyte growth factor activator(HGFA) in benign prostatic hyperplasia and prostatic carcinoma.2005
- Author(s)
  Nagakawa, Fuse et al.
- Journal Title
  
  Eur.Urology 48(4)
  
  Pages: 686-690
- Data Source
  KAKENHI-PROJECT-17591668
[Journal Article] Serum hepatocyte growth factor activator (HGFA) in benign prostatic hyperplasia and prostatic carcinoma.2005
- Author(s)
  Nagakawa O. et al.
- Journal Title
  
  Eur. Urology 48(4)
  
  Pages: 686-690
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17591668
[Journal Article] Serum hepatocyte growth factor activator (HGFA) in benign prostatic hyperplasia and prostatic carcinoma.2005
- Author(s)
  Nagakawa O, et al.
- Journal Title
  
  Eur.Urology 48(4)
  
  Pages: 686-690
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17591668
[Journal Article] Vasoactive intestinal peptide(VIP) and pituitary adenylate cyclase activating polypeptide(PACAP) stimulate interleukin-6 in prostate cancer cells and prostatic epithelial cells.2005
- Author(s)
  Nagakawa, Fuse et al.
- Journal Title
  
  Oncology Reports 13(6)
  
  Pages: 1217-1222
- Data Source
  KAKENHI-PROJECT-17591668
[Journal Article] Vasoactive intestinal peptide(VIP) and pituitary adenylate cyclase activating poly peptide(PACAP) stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells2005
- Author(s)
  Nagakawa, Fuse et al.
- Journal Title
  
  Oncology Reports (In press)
- Data Source
  KAKENHI-PROJECT-15591674
[Journal Article] Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells2005
- Author(s)
  Nagakawa, Fuse et al.
- Journal Title
  
  Oncology Reports 13
  
  Pages: 1217-1222
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15591674
[Journal Article] Serum interleukin-11 in patients with benign prostatic hyperplasia and prostate cancer.2005
- Author(s)
  Furuya, Nagakawa, Fuse et al.
- Journal Title
  
  Int.Urol.Nephrol. 37(1)
  
  Pages: 69-71
- Data Source
  KAKENHI-PROJECT-17591668
[Journal Article] Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) stimulate interleukin-6 in prostate cancer cells and prostatic epithelial cells2005
- Author(s)
  Nagakawa O, et al.
- Journal Title
  
  Oncol.Rep. 13(6)
  
  Pages: 1217-1222
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17591668
[Journal Article] Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) stimulate interleukin-6 in prostate cancer cells and prostatic epithelial cells2005
- Author(s)
  Nagakawa O. et al.
- Journal Title
  
  Oncol. Rep. 13(6)
  
  Pages: 1217-1222
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17591668
[Journal Article] Differential expression of integrin subunits in DU-145/AR prostate cancer cells2004
- Author(s)
  Nagakawa, Fuse et al.
- Journal Title
  
  Oncology Reports 12
  
  Pages: 337-341
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15591674
[Journal Article] Differential effect of chromogranin A fragment on invasion and growth of prostate cancer cells2003
- Author(s)
  Nagakawa, Fuse et al.
- Journal Title
  
  Urology 62
  
  Pages: 553-558
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15591674

1. FUSE Hideki (40143292)

# of Collaborated Projects: 3 results

# of Collaborated Products: 10 results
2. AKASHI Takuya (70345560)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results

NAGAKAWA Osamu 永川 修

Research Projects

Research Products

Co-Researchers

Androgen receptor influences the invasion and metastasis in prostate cancer molecular biological study

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Effect of VIP on invasion and production of IL-6 in prostate cancer cellsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Effect of Proatatic Neuripeptides on The Invasion of Prostate Cancer Cells.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Androgen receptor negatively influences the expression of chemokine receptors (CXCR4, CCR1) and ligand-mediated migration in prostate cancer DU-145.2006

Author(s)

Journal Title

Data Source

[Journal Article] Serum hepatocyte growth factor activator inhibitor type 1(HAI-1) and type 2(HAI-2) in prostate cancer. Prostate2006

Author(s)

Journal Title

Description

Data Source

[Journal Article] Treatment with prednisolone of hormone-refractory prostate cancer.2006

Author(s)

Journal Title

Data Source

[Journal Article] Serum hepatocyte growth factor activator inhibitor type 1 (HAI-1) and type 2 (HAI-2) in prostate cancer2006

Author(s)

Journal Title

Description

Data Source

[Journal Article] Serum hepatocyte growth factor activator inhibitor type 1(HAI-1) and type 2(HAI-2) in prostate cancer.2006

Author(s)

Journal Title

Data Source

[Journal Article] Serum hepatocyte growth factor activator(HGFA) in benign prostatic hyperplasia and prostatic carcinoma.2005

Author(s)

Journal Title

Data Source

[Journal Article] Serum hepatocyte growth factor activator (HGFA) in benign prostatic hyperplasia and prostatic carcinoma.2005

Author(s)

Journal Title

Description

Data Source

[Journal Article] Serum hepatocyte growth factor activator (HGFA) in benign prostatic hyperplasia and prostatic carcinoma.2005

Author(s)

Journal Title

Description

Data Source

[Journal Article] Vasoactive intestinal peptide(VIP) and pituitary adenylate cyclase activating polypeptide(PACAP) stimulate interleukin-6 in prostate cancer cells and prostatic epithelial cells.2005

Author(s)

Journal Title

Data Source

[Journal Article] Vasoactive intestinal peptide(VIP) and pituitary adenylate cyclase activating poly peptide(PACAP) stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells2005

Author(s)

Journal Title

Data Source

[Journal Article] Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells2005

Author(s)

Journal Title

Description

Data Source

[Journal Article] Serum interleukin-11 in patients with benign prostatic hyperplasia and prostate cancer.2005

Author(s)

Journal Title

Data Source

[Journal Article] Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) stimulate interleukin-6 in prostate cancer cells and prostatic epithelial cells2005

Author(s)

Journal Title

Description

Data Source

NAGAKAWA Osamu 永川修